

Retinoblastoma-RB
Retinoblastoma is a malignant tumor that develops in the retina, typically affecting young children. Early diagnosis allows for better eye preservation and life outcomes.
Treatment may involve chemotherapy, laser therapy, cryotherapy, or surgical removal depending on severity.
Overview And Clinical Background
Retinoblastoma originates from immature retinal cells and is often associated with genetic mutations in the RB1 gene.
It can affect one or both eyes and has a high survival rate when detected early.
Symptoms, Signs And Presentation
The condition usually presents with visible changes in the eye appearance.
Parents often notice unusual reflections or movement abnormalities.
Diagnosis Methods And Investigations
Imaging And Laboratory Tests
Accurate diagnosis involves both imaging and genetic evaluation.
Physicians use several complementary approaches to confirm retinoblastoma.
Treatment Options And Surgical Techniques
Treatment aims to save the child’s life, preserve vision, and prevent spread.
The approach depends on tumor size, location, and whether one or both eyes are affected.
Recovery, Risks And Prognosis
Children with retinoblastoma have excellent survival rates when treated early.
Visual outcomes depend on tumor size and laterality, with ongoing follow-up required to detect recurrence.
Why Choose Us
CureU Healthcare’s pediatric oncology team uses precision imaging, advanced chemotherapy, and compassionate family-centered care to ensure the best possible outcomes.
We focus equally on life preservation and quality of life improvement.
Conclusion
Retinoblastoma is a serious but highly treatable eye cancer.
Early detection and comprehensive multidisciplinary management greatly improve survival and vision preservation.